Clinical Trials Browser

Phase EARLY_PHASE1 × niraparib × 90 days × Clear all

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Phase EARLY_PHASE1 Active not recruiting

Glioblastoma, Glioma